[1] Nöth U, Rackwitz L, Steinert A F, et al. Cell delivery therapeutics for musculoskeletal regeneration[J]. Adv Drug Deliv Rev, 2010, 62(7-8):765-783.
[2] Chen Y, Shao J Z, Xiang L X, et al. Mesenchymal stem cells: A promising candidate in regenerative medicine[J]. Int J Biochem Cell Biol, 2008, 40(5):815-820.
[3] Wu X, Tao R. Hepatocyte differentiation of mesenchymal stem cells[J]. Hepatobiliary Pancreat Dis Int, 2012, 11(4):360-371.
[4] Reed S A, Johnson S E. Equine umbilical cord blood contains a population of stem cells that express Oct4 and differentiate into mesodermal and endodermal cell types[J]. J Cell Physiol, 2008, 215(2): 329-336.
[5] Yan M, Sun M, Zhou Y, et al. Conversion of human umbilical cord mesenchymal stem cells in wharton's jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: Potential therapeutic application for parkinson's disease in a rhesus monkey model[J]. PLoS One, 2013, 8(5):e64000.
[6] Somoza R, Juri C, Baes M, et al. Intranigral transplantation of epigenetically induced bdnf-secreting human mesenchymal stem cells: Implications for cell-based therapies in parkinson's disease[J]. Biol Blood Marrow Transplant, 2010, 16(11):1530-1540.
[7] Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J]. Cell, 2006, 126(4):663-676.
[8] Lewis B P, Burge C B, Bartel D P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets[J]. Cell, 2005, 120(1):15-20.
[9] Du T, Zamore P D. microPrimer: The biogenesis and function of microRNA[J]. Development, 2005, 132(21):4645-4652.
[10] Wienholds E, Kloosterman W P, Miska E, et al. microRNA expression in zebrafish embryonic development[J]. Science, 2005, 309(5732):310-311.
[11] Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement[J]. Cytotherapy, 2006, 8(4):315-317.
[12] Colleoni S, Bottani E, Tessaro I, et al. Isolation, growth and differentiation of equine mesenchymal stem cells: Effect of donor, source, amount of tissue and supplementation with basic fibroblast growth factor[J]. Veterinary Research Communications, 2009, 33(8):811-821.
[13] 张焱如,刘宗正,韦林盖,等.蒙古马骨髓间充质干细胞的分离培养及多向分化潜能的研究[J].畜牧兽医学报, 2011, 42(10): 1357-1361.
[14] 韦林盖,周欢敏,张焱如,等. 蒙古羊骨髓间充质干细胞的分离培养及多向诱导分化[J].中国畜牧兽医, 2013, 40(8): 7-12.
[15] Guan L P, Yu J, Huang B, et al. In vitro differentiation of human skin-derived mesenchymal stem cells into lymphocytes: Possibility evaluation[J]. Journal of Clinical Rehabilitative Tissue Engineering Research, 2010, 14(19):3601-3605.
[16] Alves da Silva M L, Costa-Pinto A R, Martins A, et al. Conditioned medium as a strategy for human stem cells chondrogenic differentiation[J]. Journal of Tissue Engineering and Regenerative Medicine, 2015,9(6): 714-723.
[17] Jayasuriya C T, Zhou F H, Pei M, et al. Matrilin-3 chondrodysplasia mutations cause attenuated chondrogenesis, premature hypertrophy and aberrant response to TGF-β in chondroprogenitor cells[J]. International Journal of Molecular Sciences, 2014,15(8): 14555-14573.
[18] Farndale R W, Sayers C A, Barrett A. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures[J]. Connect Tissue Res, 1982, 9: 247-248.
[19] Murata D, Miyakoshi D, Hatazoe T, et al. Multipotency of equine mesenchymal stem cells derived from synovial fluid[J]. Vet J, 2014, 202(1):53-61.
[20] Yoo H J, Yoon S S, Park S Y, et al. Gene expression profile during chondrogenesis in human bone marrow derived mesenchymal stem cells using a cDNA microarray[J]. Journal of Korean Medical Science, 2011, 26(7):851-858. |